Background Background: In response to the COVID-19 pandemic, the US Substance Abuse
and Mental Health Services Administration (SAMHSA) allowed for an increase in …

Post-release opioid-related overdose mortality is the leading cause of death among people
released from jails or prisons (PRJP). Informed by the proximate determinants framework, …

Importance Methadone access may be uniquely vulnerable to disruption during COVID-19,
and even short delays in access are associated with decreased medication initiation and …

Background Within the United States, there is a shortage of opioid treatment programs (OTPs),
facilities which dispense methadone for opioid use disorder. It is unknown how pharmacy-…

Methods| The outcome was the minimum drive time in minutes from the county mean center
of population to the nearest OTP, FQHC, and dialysis center using the Esri ArcGIS rural drive-…

Importance Given that COVID-19 and recent natural disasters exacerbated the shortage of
medication for opioid use disorder (MOUD) services and were associated with increased …

Introduction In response to the COVID-19 pandemic, a federal exemption allowed stable and
less stable patients greater take-home doses of methadone. We assessed the adoption of …

In the US, methadone treatment can only be provided to patients with opioid use disorder (OUD)
through federal and state-regulated opioid treatment programs (OTPs). There is a …

In 1974, President Nixon signed the Narcotic Addiction Treatment Act, which gave statutory
authority to the regulations governing the provision of methadone for the treatment of opioid …

Background Within the United States (US), because racial/ethnic disparities in cannabis
arrests continue, and cannabis legalization is expanding, understanding disparities in …